Results 61 to 70 of about 42,854 (222)

CEREBRAL VENOUS THROMBOSIS IN OBSTETRICS AND GYNECOLOGY

Акушерство, гинекология и репродукция, 2016
Cerebral venous thrombosis is a rare, life-threatening condition, which has now become more frequently diagnosed by advances in imaging techniques. The most common risk factors for cerebral venous thrombosis include pregnancy, postpartum period, use of ...
A. D. Makatsariya, S. V. Akinshina, V. O. Bitsadze   +2 more
doaj  

Incidence of Thrombosis at Different Sites During the Follow-Up Period in Essential Thrombocythemia: A Systematic Review and Meta-Analysis

Clinical and Applied Thrombosis/Hemostasis, 2023
Thrombotic events are the most frequent manifestations of essential thrombocythemia (ET). The objective of this study is to determine the incidence of thrombosis at different sites on follow-up in patients with ET. We searched PubMed, Web of Science, and
Dehao Wang MD, Xinyue Yu MS, Yan Sun MD, Yan Lv MS, Yumeng Li MD, Pei Zhao MD, Jicong Niu MS, Yanyu Zhang MD, Yi Chen MB, Ke Chen MD, Zhuo Chen MD, Weiyi Liu MD, Mingjing Wang MD, Xiaomei Hu MD   +13 more
doaj   +1 more source

Cerebral Sinus Thrombosis with Coexisting Secondary Hypoparathyroidism: Case Report for Clinical Education

Archives of Anesthesia and Critical Care, 2021
Cerebral venous sinus thrombosis is a rare and infrequent condition in pregnant women. Hemorrhagic infarction can occur in early stages of cerebral venous thrombosis.
Mohammad Reza Zeraati, Hojjat Torkmandi, Zahra Ghahramani, Mohammad Abdi   +3 more
doaj   +1 more source

Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol. [PDF]

, 2016
INTRODUCTION: Cerebral venous thrombosis (CVT) is a rare cerebrovascular condition accounting for
Ioana Cotlarciuc, Thomas Marjot, Muhammad S Khan, Sini Hiltunen, Elena Haapaniemi, Tiina M Metso, Jukka Putaala, Susanna M Zuurbier, Matthijs C Brouwer, Serena M Passamonti, Paolo Bucciarelli, Emanuela Pappalardo, Tasmin Patel, Paolo Costa, Marina Colombi, Patrícia Canhão, Aleksander Tkach, Rosa Santacroce, Maurizio Margaglione, Giovanni Favuzzi, Elvira Grandone, Donatella Colaizzo, Kostas Spengos, Antonio Arauz, Amanda Hodge, Reina Ditta, Stephanie Debette, Marialuisa Zedde, Guillaume Pare, José M Ferro, Vincent Thijs, Alessandro Pezzini, Jennifer J Majersik, Ida Martinelli, Jonathan M Coutinho, Turgut Tatlisumak, Pankaj Sharma
core   +1 more source

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

American Journal of Hematology, EarlyView.
The WAVe stdudy‐ A multicenter prospective cohort study of wieght‐adjusted dalteparin in patients over 90 kg with acute cancer‐associated venous thromboembolism. ABSTRACT Patients with cancer‐associated thrombosis (CAT) are commonly treated with low‐molecular‐weight heparin (LMWH), but whether dose capping is needed in patients over 90 kg is unclear ...
Tzu‐Fei Wang, Erik Yeo, Peter L. Gross, Chantal Séguin, Cynthia Wu, Sudeep Shivakumar, Ranjeeta Mallick, Aurélien Delluc, Julien D'Astous, Miriam Kimpton, Guillaume Roberge, Deborah M. Siegal, Tobias Tritschler, Grégoire Le Gal, Marc Carrier   +14 more
wiley   +1 more source

Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis [PDF]

, 2016
Reviewpublished_or_final_versio
Günther, A, Kwan, SKJ, Price, M
core   +1 more source

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres

British Journal of Clinical Pharmacology, EarlyView.
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr, Anette D. Kjeldsen, Annette D. Fialla, Anne‐Emmanuelle Fargeton, Alexandre Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, Hans‐Jurgen Mager, Jean‐Christophe Saurin, Jens Kjeldsen, Josefien Hessels, Marco C. Post, Robert Mandic, Sanne Boerman, Stefan Kasper‐Virchow, Sören Möller, Urban Geisthoff, Sophie Dupuis‐Girod   +18 more
wiley   +1 more source

Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy [PDF]

, 2017
Warfarin and antihyperlipidemics are commonly co-prescribed. Some antihyperlipidemics may inhibit warfarin deactivation via the hepatic cytochrome P450 system.
Bilker, Warren B., Brensinger, Colleen M., Hennessy, Sean, Kimmel, Stephen E., Leonard, Charles E., Whitaker, Heather J.   +5 more
core   +2 more sources

Cerebral venous thrombosis in otorhinolaryngology. Case report

Consilium Medicum, 2022
A violation of cerebral circulation, in which a blood clot forms in the venous system of the brain with the formation of an obstruction of the dural sinus, one or more veins of the brain is called cerebral venous thrombosis.
Aleksandr A. Krivopalov, Aleksandr Yu. Shcherbuk, Yurii A. Shcherbuk, Irina I. Sarkisyan, Polina A. Shamkina, Alexandra I. Glyshchenko   +5 more
doaj   +1 more source

Prevention of stillbirths associated with umbilical cord abnormalities: A clinico‐pathological overview

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Stillbirths affect millions of pregnancies every year worldwide, and obstruction of the umbilical cord blood flow is one of the main causes of fetal death. This review provides a clinico‐pathological overview of cord abnormalities potentially associated with antepartum stillbirth, describing the mechanism determining the death and addressing ...
Laura Avagliano, Chiara Parodi, Valentina Massa, Gaetano Bulfamante   +3 more
wiley   +1 more source